Company profile

Ardelyx, Inc.

Pipeline2 assets

tenapanorIBSRELA / small molecule / Gastrointestinal
Chronic Idiopathic Constipation (CIC)Phase III
RDX10531RDX10531 / NHE3 / small molecule / Multiple therapeutic areas
UndisclosedPreclinical

No recent headlines yet.

New company coverage will appear here as soon as it is picked up.